ResearcherBaylor College of MedicineNo recent work listed

Emily L. LaPlante

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4044-7187; OpenAlex author ID A5024433269. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

XDec-CHI reveals immunosuppressive interactions in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2022.105249 ↗
Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of retinoic acid receptor gamma and AKT by … Co-author DOI 10.1038/s41389-020-00245-3 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qizhi Cathy Yao · 2 shared papers, 2020–2022 · strength 0.34
- Paper XDec-CHI reveals immunosuppressive interactions in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2022.105249 ↗
- Paper Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of … DOI 10.1038/s41389-020-00245-3 ↗
Aleksandar Milosavljevic · 2 shared papers, 2020–2022 · strength 0.34
- Paper XDec-CHI reveals immunosuppressive interactions in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2022.105249 ↗
- Paper Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of … DOI 10.1038/s41389-020-00245-3 ↗
Dongliang Liu · 1 shared paper, 2020 · strength 0.13
- Paper Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of … DOI 10.1038/s41389-020-00245-3 ↗
Eugene Lurie · 1 shared paper, 2020 · strength 0.13
- Paper Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of … DOI 10.1038/s41389-020-00245-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.